SCHEMBL28071047

SCHEMBL28071047

NNC(C(=O)[N+](=O)[O-])(c1ccccc1)[N+](=O)[O-]

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.36
CYP1A2 P05177 3/20 0.35
CYP2D6 P10635 1/20 0.35
ALDH1A1 P00352 6/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
LMNA P02545 3/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KCNN4 O15554 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL601390 0.75 MAPT (0.41) CYP1A2ALDH1A1KMT2AMEN1LMNA
SCHEMBL1132752 0.73 CYP1A2 (0.38) CYP1A2ALDH1A1KMT2ALMNAMAPT
SCHEMBL9235877 0.71 CYP19A1 (0.39) CTSDCYP1A2ALDH1A1KMT2ALMNA
SCHEMBL6465771 0.70 MAPT (0.37) CYP1A2CYP2D6ALDH1A1KMT2AMEN1
SCHEMBL114442 0.67 ALDH1A1 (0.46) CYP1A2ALDH1A1KMT2AMEN1LMNA
SCHEMBL11863776 0.67 CTSD (0.39) CTSDCYP1A2CYP2D6ALDH1A1KMT2A
SCHEMBL15994878 0.66 CYP1A2 (0.44) CYP1A2CYP2D6ALDH1A1KMT2ALMNA
SCHEMBL27523837 0.66 ALDH1A1 (0.34) CTSDCYP1A2CYP2D6ALDH1A1KMT2A
SCHEMBL2056618 0.65 KCNN4 (0.48) CYP1A2CYP2D6ALDH1A1KMT2ALMNA
SCHEMBL4388492 0.65 CYP1A2 (0.45) CYP1A2CYP2D6ALDH1A1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105769860-A Application of clomethiazole as medicine for preventing and treating liver and esophageal disease 乔海灵 2016-07-20 CN disclosed
CN-105664181-A Application of chlorzoxazone serving as probe drug in determination of metabolic activity of human body to nitrosamine compounds 乔海灵 2016-06-15 CN disclosed